Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering of Common Stock
November 10, 2021 08:30 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Announces Proposed Underwritten Public Offering of Common Stock
November 09, 2021 16:30 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Launches Therapeutic Experience Program; NYU Langone Health Is Initial Clinical Trial Site
November 08, 2021 07:05 ET
|
Helius Medical Technologies, Inc.
-- Multi-center, company-sponsored, open label observational interventional trial to evaluate impact of subjects’ adherence to PoNS® therapy for gait improvement in Multiple Sclerosis ---- Program to...
Helius Medical Technologies, Inc. Receives PoNS® Market Authorization in Australia
November 04, 2021 06:55 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today announced it...
Helius Medical Technologies, Inc. to Release Third Quarter 2021 Financial Results on November 10, 2021
November 01, 2021 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
October 29, 2021 16:30 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. to Present at the Dawson James Small Cap Growth Conference
October 12, 2021 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. to Present at the Benzinga Healthcare Small Cap Conference
September 22, 2021 16:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors
September 14, 2021 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...